Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-09-0058PMID 19723918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study

  2009cited by this paper
• A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer

  2009cited by this paper
• Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

  2008cited by this paper
• Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

  2007cited by this paper
• Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer

  2007cited by this paper
• Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.

  2007cited by this paper
• Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

  2007cited by this paper
• Studies of genes and cancer survival: pieces of the puzzle.

  2007cited by this paper
• Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer

  2007cited by this paper
• Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.

  2007cited by this paper
• Prostate cancer progression and survival in BRCA2 mutation carriers.

  2007cited by this paper
• Identification of germline MLH1 alterations in familial prostate cancer.

  2006cited by this paper
• Frequency and nature of hMSH6 germline mutations in Polish patients with colorectal, endometrial and ovarian cancers

  2006cited by this paper
• Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.

  2006cited by this paper
• Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer.

  2005cited by this paper
• Cancer Epidemiol Biomarkers Prev

  2004cited by this paper
• NBS1 Is a Prostate Cancer Susceptibility Gene

  2004cited by this paper
• The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours

  2004cited by this paper
• Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

  2004cited by this paper
• The Tumor Spectrum in the Lynch Syndrome

  2004cited by this paper
• Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31

  2003cited by this paper
• Where are the prostate cancer genes?—A summary of eight genome wide searches

  2003cited by this paper
• Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.

  2003influential reference
• Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.

  2003cited by this paper
• Mutations in CHEK2 associated with prostate cancer risk.

  2003cited by this paper
• Prostate cancer is part of the hereditary non‐polyposis colorectal cancer (HNPCC) tumor spectrum

  2003cited by this paper
• Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence

  2002cited by this paper
• Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.

  2001cited by this paper
• Defects of DNA mismatch repair in human prostate cancer.

  2001cited by this paper
• Low frequency of microsatellite instability in hereditary prostate cancer

  2001cited by this paper
• Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer.

  2001cited by this paper
• MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

  2001cited by this paper
• Family history and the risk of prostate cancer.

  2000cited by this paper
• The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.

  2000cited by this paper
• Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

  2000cited by this paper
• Genetic predisposition to prostate cancer

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.

  1996cited by this paper
• Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.

  1996cited by this paper
• Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines.

  1995cited by this paper
• Duchenne Muscular Dystrophy

  1994cited by this paper
• Mendelian inheritance of familial prostate cancer.

  1992cited by this paper
• Family history and the risk of prostate cancer

  1990cited by this paper

• The Role of Genetic Testing in Localized Prostate Cancer.

  2025cites this paper
• Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy.

  2025cites this paper
• Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate Cancer.

  2025cites this paper
• Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes

  2024cites this paper
• Genetics of prostate cancer: a review of latest evidence

  2024cites this paper
• Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome

  2024cites this paper
• Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer

  2023cites this paper
• Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome

  2023cites this paper
• 2023 Canadian Urological Association guideline: Genetic testing in prostate cancer.

  2023cites this paper
• Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications

  2023cites this paper
• Precision intervention for prostate cancer: Re-evaluating who is at risk.

  2022cites this paper
• Lynch Syndrome-Associated Cancers Beyond Colorectal Cancer.

  2022cites this paper
• Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene

  2022cites this paper
• Positive Impact of Implementing a Comprehensive Genetic Testing Protocol for Prostate Cancer Patients in a Multi-disciplinary Uro-oncology Practice

  2022cites this paper
• Prostate Cancer Update 2022

  2022cites this paper
• Mismatch repair is a double-edged sword in the battle against microsatellite instability

  2022cites this paper
• An appraisal of genetic testing for prostate cancer susceptibility

  2022cites this paper
• Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry

  2022cites this paper
• Clinical Multigene Testing for Prostate Cancer.

  2021cites this paper
• Clinicopathological, Immunohistochemical, and PMS2 Gene Expression Profiling of Patients with Sporadic Colorectal Cancer.

  2021cites this paper
• IgA-dominated humoral immune responses govern patients' outcome in endometrial cancer.

  2021cites this paper
• Genetics of prostate cancer and its utility in treatment and screening.

  2021cites this paper
• A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

  2021cites this paper
• Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk

  2021cites this paper
• Cancer Genetics and Epigenetics in Cancer Risk Assesment

  2021cites this paper
• Initial Findings from a High Genetic Risk Prostate Cancer Clinic.

  2021cites this paper
• Familiäres Prostatakarzinom und genetische Prädisposition

  2021influential citation
• Spectrum and Frequency of Tumors, Cancer Risk and Survival in Chilean Families with Lynch Syndrome: Experience of the Implementation of a Registry

  2020cites this paper
• ANO7 in aggressive prostate cancer

  2020cites this paper
• The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine

  2020cites this paper
• The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

  2020cites this paper
• Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications

  2020cites this paper
• Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review

  2020cites this paper
• Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer.

  2020cites this paper
• Reduced mismatch repair gene expression and functional deficiency as indicators of Lynch syndrome

  2020cites this paper
• An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer

  2020cites this paper
• Clinical implications of mismatch repair deficiency in prostate cancer.

  2019cites this paper
• DNA Damage Response in Prostate Cancer.

  2019cites this paper
• Genomics of Prostate Cancer: What Nurses Need to Know.

  2019cites this paper
• Metastatic Prostate Cancer

  2019cites this paper
• Bringing Prostate Cancer Germline Genetics into Clinical Practice.

  2019cites this paper
• Role of the DNA damage response in prostate cancer formation, progression and treatment

  2019cites this paper
• Genetic epidemiology of colorectal cancer and associated cancers.

  2019cites this paper
• Alpha () satellite RNA and MSH2 gene: potential candidates for diagnostic/prognostic blood's biomarker of prostate cancer Graduation Thesis

  2019cites this paper
• Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer

  2018cites this paper
• Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities

  2018cites this paper
• Genetic testing for hereditary prostate cancer: Current status and limitations

  2018cites this paper
• Predicting the evolution of Escherichia coli by a data-driven approach

  2018cites this paper
• Síndrome de Lynch: impacto de la caracterización de familias en base a estudios genéticos

  2018cites this paper
• Prognostic Significance of Immunohistochemical MSH2 Expression in Prostate Cancer

  2018cites this paper
• Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

  2018cites this paper
• The International Mismatch Repair Consortium

  2018cites this paper
• Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

  2017cites this paper
• MSH2 Loss in Primary Prostate Cancer

  2017cites this paper
• The molecular biology of prostate cancer: current understanding and clinical implications

  2017cites this paper
• Inherited Predisposition to Prostate Cancer: From Gene Discovery to Clinical Impact.

  2017cites this paper
• Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

  2017cites this paper
• Defining New Colorectal Cancer Syndromes in a Population-based Cohort of the Disease.

  2017cites this paper
• Pharmacologic Dose Testosterone to Treat Castration-Resistant Prostate Cancer: Mechanisms of Action and Drivers of Response

  2017cites this paper
• Prevalencia del Síndrome de Lynch en Pacientes con Cáncer de Endometrio no Seleccionado

  2017cites this paper
• Integrated genomic characterization of cancer genes in glioma

  2017cites this paper
• Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

  2017cites this paper
• Frequent mismatch-repair defects link prostate cancer to Lynch syndrome

  2016cites this paper
• A Case of Prostate Cancer in Lynch Syndrome.

  2016cites this paper
• A cohort analysis of men with a family history of BRCA 1 / 2 and Lynch mutations for prostate

  2016cites this paper
• A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer

  2016cites this paper
• Microsatellite Instability and its Significance to Hereditary and Sporadic Cancer

  2016cites this paper
• Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer

  2016cites this paper
• [Lynch syndrome and risk of prostate cancer; review of the literature].

  2015cites this paper
• The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer

  2015cites this paper
• Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer

  2015cites this paper
• Genderspezifische Aspekte des Lynch-Syndroms – Ein Update

  2015cites this paper
• Clinical Diagnosis and Therapy of Colorectal Cancer

  2015cites this paper
• ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

  2015cites this paper
• РАК ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ И НАСЛЕДСТВЕННЫЕ СИНДРОМЫ

  2015cites this paper
• Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells

  2015cites this paper
• Clinical management of hereditary colorectal cancer syndromes

  2015cites this paper
• Mismatch Repair Deficient Cancer Diagnostic Aspects in Colorectal Cancer and the Role of Urological Cancer in Lynch Syndrome

  2015influential citation
• Screening and Prevention of Extra Colonic Cancer in Hereditary Non-polyposis Colorectal Cancer

  2015cites this paper
• Genderspezifische Aspekte des Lynch-Syndroms – Ein Update

  2015cites this paper
• Inherited Cancer-Predisposing Syndomes

  2014cites this paper
• Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

  2014cites this paper
• Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer.

  2014cites this paper
• Risk profiling: Familial colorectal cancer

  2014cites this paper
• Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis

  2014cites this paper
• DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells

  2014cites this paper
• High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry

  2014cites this paper
• The dual nature of mismatch repair as antimutator and mutator: for better or for worse

  2014cites this paper
• Germline genetic variants associated with prostate cancer and potential relevance to clinical practice.

  2014cites this paper
• Risk of Prostate Cancer in Lynch Syndrome: A Systematic Review and Meta-analysis

  2014influential citation
• Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.

  2014cites this paper
• Prostate cancer incidence in males with Lynch syndrome

  2014cites this paper
• Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

  2014cites this paper
• Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

  2014cites this paper
• Mismatch repair proteins in recurrent prostate cancer.

  2013cites this paper
• Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.

  2013cites this paper
• Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

  2013cites this paper
• Copy Number Variation in Hereditary Non-Polyposis Colorectal Cancer

  2013cites this paper
• Elevated risk of prostate cancer among men with Lynch syndrome.

  2013cites this paper
• Application of a five-tiered scheme for standardized classification of 2 , 360 unique mismatch repair gene variants lodged on the InSiGHT locus-specific database

  2013cites this paper